An observational study in Blood Pressure Measurement, sponsored by Philips Clinical & Medical Affairs Global. Recruiting at 1 site in United States. Open to participants aged 3 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.
Sponsored by Philips Clinical & Medical Affairs Global (part of Philips) · Observational
The main purpose of this study is to assess the equivalence between blood pressure measurements obtained using the Philips iNIBP system and those determined by the auscultatory reference method.
The main purpose of the study is to determine the equivalence in the mean difference (bias) and standard deviation (SD) between inflationary based non-invasive blood pressure (iNIBP) measurements (systolic blood pressure, diastolic blood pressure, mean arterial pressure) and reference auscultatory BP measurements, assessed using a same-arm sequential measurement method with dual independent observers.
Philips Clinical & Medical Affairs Global is the lead sponsor of 85 studies on the registry; 25 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 12 (80%) have results posted.
Counted across the registry records on this site, refreshed daily.
The study population will include a minimum of 85 to 150, pediatric and adult volunteers.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants with clotting disorders.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Blood Pressure Measurement
The Philips inflationary based algorithm of the IntelliVue X3 Monitor will be used to measure systolic blood pressure, diastolic blood pressure, and mean arterial pressure compared to the ausculatory reference method.
Compare blood measurements obtained from the Philips Inflationary-based non-invasive blood pressure (iNIBP) system to the accepted auscultatory reference method.
Compare blood measurements (systolic blood pressure, diastolic blood pressure, and mean arterial pressure) obtained from the Philips Inflationary-based non-invasive blood pressure (iNIBP) system to the accepted auscultatory reference method.
Time frame: Up to 8 weeks
Compare the pulse rate obtained from the Philips Inflationary-based non-invasive blood pressure (iNIBP) system to the pulse rate obtained from a refence PPG obtained from a pulse oximetry sensor.
Compare the pulse rate obtained from the Philips Inflationary-based non-invasive blood pressure (iNIBP) system to the pulse rate obtained from a refence PPG obtained from a pulse oximetry sensor.
Time frame: Up to 8 weeks
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Philips Clinical & Medical Affairs Global →